A Promising Alzheimer’s Drug Doesn’t Work After All
The first drug designed to treat Alzheimer’s failed to show dramatic benefit

The third try wasn’t the charm for Eli Lilly’s Alzheimer’s drug solanezumab. In EXPEDITION3, the third test of the drug since it was developed in 2006, the compound failed once again to show significant benefit for people with mild forms of the disease.....

http://time.com/4581267/eli-lilly-company-alzheimers-disease-drug/?
Like
Comment
Share